Pharmafile Logo
Pharmafocus logo
Advanced Search

South Africa study shows J&J booster 85% effective against Omicron hospitalisation

January 14, 2022
Medical Communications

The head of South Africa’s Medical Research Council (SAMRC) has revealed that a J&J booster shot is 85% effective in …

News

First melanoma test to offer reassurance of low risk of cancer spread

January 14, 2022
Medical Communications

A new test reliably predicting the spread or return of the most deadly form of skin cancer has been developed …

News

WHO recommend two new COVID-19 treatments

January 14, 2022
Medical Communications

WHO approved two new treatments for COVID-19 on 14 January, as Omicron cases continue globally, and WHO predicting half of …

News

Benevolent AI and AstraZeneca expand collaboration on heart failure and systemic lupus discovery

January 13, 2022
Business Services

Leading clinical stage AI drug discovery company, Benevolent AI, has expanded its AI-driven drug discovery collaboration with AstraZeneca. This means …

News

Abivax receive EMA scientific advice support for ulcerative colitis trial

January 13, 2022
Business Services

Abivax have received scientific advice from the EMA supporting advancing ABX464 into Phase III clinical testing, for the treatment of …

News

Antifungal Cresemba (isavuconazole) approved for aspergillosis patients in China

January 13, 2022
Business Services

Basilea Pharmaceutica, announced that its license partner, Pfizer, has received a Drug Approval License from the National Medical Products Administration …

News

PCN-101 R-ketamine Programme receives FDA Investigational New Drug clearance

January 13, 2022
Business Services

The FDA has given Investigational New Drug (IND) clearance to atai Life Sciences, to conduct a clinical DDI study of …

News

White House announces plans to double COVID-19 tests for schools

January 12, 2022
Research and Development

The Biden administration announced new plans to increase COVID-19 protection in schools in the US, as the Omicron variant continues …

News

South Korea Ministry of Food and Drug Safety approves Novavax COVID-19 vaccine

January 12, 2022
Research and Development

Biotechnology company Novavax, alongside SK bioscience, a vaccine business subsidiary of Korea-based SK Group, announced that South Korea’s Ministry of …

News

WHO experts warn against repeated boosters as strategy against COVID-19

January 12, 2022
Research and Development

Repeating booster doses of the original COVID-19 vaccines is not a viable strategy against emerging variants, WHO has shared, predicting …

News

MHRA Approves Vertex’s Kaftrio combination with ivacaftor for Children With cystic fibrosis

January 12, 2022
Research and Development

Vertex Pharmaceuticals have announced the MHRA approval of the label extension of Kaftrio® (ivacaftor/tezacaftor/elexacaftor) in a combination regimen with ivacaftor, …

News

Latest study shows positive results of CanSinoBIO’s inhaled COVID-19 vaccine as booster

January 11, 2022
Manufacturing and Production

CanSino Biologics has announced that a heterologous booster with one dose of the Inhalation Convidecia for adults aged 18 years …

News

Novartis to seek FDA Emergency Use Approval approval for new COVID-19 therapy

January 11, 2022
Manufacturing and Production

Novartis shared on the 10 January, that positive data from a clinical trial of COVID-19 therapeutic drug ensovibep, has prompted …

News

Largest Phase III hemophilia trial produces positive results

January 11, 2022
Manufacturing and Production

BioMarin Pharmaceutical has revealed positive results from its ongoing Phase III GENEr8-1 trial on the viability of valoctocogene roxaparvovec as …

News

Pfizer’s Omicron vaccine to begin human trials late January

January 11, 2022
Manufacturing and Production

Albert Bourla, the CEO of Pfizer, said a COVID-19 vaccine specifically targeting the Omicron variant of the virus, alongside other …

News

Trial finds new CAR T-cell therapy is effective at killing cancer cells

January 10, 2022
Sales and Marketing

A Phase I clinical trial funded by the NIHR Invention for Innovation (i4i) programme, and supported by the NIHR UCLH …

News

European Commission approves Lumykras for lung cancer patients

January 10, 2022
Sales and Marketing

The European Commission (EC) has granted conditional marketing authorisation for Lyumykras (sotorasib), a first-in-class KRAS inhibitor, for the treatment of …

News

FDA approval of QUVIVIQ (daridorexant) for the treatment of insomnia

January 10, 2022
Sales and Marketing

Idorsia Ltd has announced the FDA approval of QUVIVIQ™ (daridorexant) 25 mg and 50 mg for the treatment of adult …

News

Phase III trial into lebrikizumab shows positive results for atopic dermatitis patients

January 10, 2022
Sales and Marketing

Almirall has reported positive results from their Phase III trial into lebrikizumab, which demonstrated significant improvement and itch relief when …

News
mufid-majnun-oi20ehignd4-unsplash

Canada to procure 20,000 doses of GSK COVID-19 antibody therapy

January 7, 2022
Medical Communications

GlaxoSmithKline Plc. has shared that it has signed agreements with the Government of Canada to supply 20,000 doses of Sotrovimab, …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025